Safe injection techniques

Randomized clinical trial to assess pain and bruising in medicines administered by means of subcutaneous and intramuscular needle injection: Is it necessary to have needles changed?

“…One study recommends changing needles after aspiring the drug to guarantee cleanliness, needle cutting, adequate caliber and length, thus avoiding pain and contact between the drug and subcutaneous tissue (18) .…”

An evidence based protocol for the prevention of upper arm injury related to vaccine administration (UAIRVA)

“…[13][14][15][16] However, with this method there is no agreement on the position of injection, with variable distances below the acromion being recommended, measured as centimeters or finger breadths/ widths. Another technique, also with strong nursing support, [17][18][19][20][21][22] involves location of the acromion and a line drawn laterally across the deltoid muscle from the apex of the anterior axilla.…”

Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials

“…Patient reported outcomes from phase 3 clinical trials camille Reygrobellet, 1 Muriel Viala-Danten, 2 Juliette Meunier, 2 Françoise Weber 1 and Van Hung Nguyen technique involves holding the skin taught with one hand, then inserting a narrow-gauge needle, bevel-up, into the skin at an angle of approximately 15° with the skin surface. 2 Recent technological innovations in the field of drug delivery have overcome these difficulties and have allowed the intradermal route to be reconsidered for routine vaccination.…”

“…2 Recent technological innovations in the field of drug delivery have overcome these difficulties and have allowed the intradermal route to be reconsidered for routine vaccination. 3 An intradermal influenza vaccine with one formulation specifically for adults older than 60 years and a second formulation specifically for adults younger than 60 years, has been developed by Sanofi Pasteur using a novel intradermal microinjection system (Soluvia TM , BD, Becton, Dickinson and Company, Franklin Lakes, NJ).…”

“…3 An intradermal influenza vaccine with one formulation specifically for adults older than 60 years and a second formulation specifically for adults younger than 60 years, has been developed by Sanofi Pasteur using a novel intradermal microinjection system (Soluvia TM , BD, Becton, Dickinson and Company, Franklin Lakes, NJ). 2,4,5 This injection system was developed specifically to target the dermal immune system, providing a convenient, reliable and easy-to use intradermal vaccination. 6 It features a pre-filled, ready-to-use, 0.1 ml glass syringe and a narrow gauge, 1.5 mm long needle that is inserted perpendicularly into the skin.…”